Business Name: |
Centro Medico Promed |
Contact Person: |
Renato Beloucat, Manager |
Address: |
3780 Holcomb Bridge Road # East, Norcross, Georgia 30092 |
Phone Number: |
(770) 798-9799 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Founding Year: |
2009 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6214930 |
Share This Business: |
|
Related Businesses: |
Physicinjobs Com - Norcross, GA 30092 Emory Eastside Medical Center - Norcross, GA 30092 Singhal Sunit K MD - Norcross, GA 30092 Futrell Danny W MD - Norcross, GA 30092 Purohit Bhumiben S MD - Norcross, GA 30092 Kumareswaran Mailupillai MD - Norcross, GA 30092 Abrams Jeffrey MD - Norcross, GA 30092 Wyatt David J MD - Norcross, GA 30092 Cole Louis D MD - Norcross, GA 30092 Barnwell Kenneth W MD - Norcross, GA 30092 Wolff Richard M MD - Norcross, GA 30092 Foreman Jr Charles S MD - Norcross, GA 30092 Williams Tina V MD - Norcross, GA 30092 Shukla Sanjay K MD - Norcross, GA 30092 Tesfaye Md - Norcross, GA 30092 Parikh Naresh K MD - Norcross, GA 30092 Bai Fang USA - Norcross, GA 30092 Zager Sheri MD - Norcross, GA 30092 Clement Edmund R MD - Norcross, GA 30092 Hodge Roy P MD - Norcross, GA 30092 |
The company Centro Medico Promed provides B2C services in the form of Doctors from its single location in Georgia.
1 to 4 employees work for Centro Medico Promed, and the business now earns $500.000 to $999.999 per annum.
Centro Medico Promed was launched in 2009 and is classified under SIC code and category 8011 , and NAICS number and grouping 6214930 .
To contact Centro Medico Promed, please call Renato Beloucat, Manager with the phone number (770) 798-9799 or visit its single location at 3780 Holcomb Bridge Road # East in Norcross, Georgia 30092.
The location of the single location can also be found using the coordinates 33.96264,-84.25028.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.